Presynaptic effects of levodopa and their possible role in dyskinesia-Reference-Cited by-同舟云学术

Presynaptic effects of levodopa and their possible role in dyskinesia

Published:2014-12-01 Issue:1 Volume:30 Page:45-53
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Mosharov Eugene V.¹,Borgkvist Anders¹,Sulzer David¹²³

Affiliation:

1. Departments of Neurology; Columbia University Medical Center; New York New York USA

2. Departments of Psychiatry; Columbia University Medical Center; New York New York USA

3. Departments of Pharmacology; Columbia University Medical Center; New York New York USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference114 articles.

1. Der L-3,4-dioxyphenylalanin (DOPA) Effekt bei der Parkinson-akinesia (Effect of L-3,4-dioxyphenylalanine (DOPA) on Parkinson's disease akinesia.);Birkmayer;Wien Klin Wochenschr,1961

2. Aromatic amino acids and modification of parkinsonism;Cotzias;N Engl J Med,1967

3. Effects of phosphorylation on binding of catecholamines to tyrosine hydroxylase: specificity and thermodynamics;Ramsey;Biochemistry,2000

4. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease;Hadjiconstantinou;CNS Neurosci Ther,2008

5. Autoreceptor regulation of dopamine synthesis;Wolf;Ann N Y Acad Sci,1990

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy;Internal Medicine;2024-09-01

2. Translational profiling reveals novel gene expression changes in the direct and indirect pathways in a mouse model of LDOPA-induced dyskinesia;2024-06-10

3. 5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapses;2024-03-14

4. Parkinson’s disease and levodopa-induced dyskinesias: a quantitative analysis through 99mTc-TRODAT-1 SPECT imaging of the brain;Radiologia Brasileira;2024

5. Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions;Heliyon;2023-11